Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 54,386 | 36,934 | 53,848 | 39,818 | 19,552 |
| Operating Income | -54,386 | -36,934 | -53,848 | -39,818 | -19,552 |
| Other Income | 1,713 | 1,623 | 1,893 | 48 | 87 |
| Pre-tax Income | -52,673 | -35,311 | -51,955 | -39,770 | -19,465 |
| Net Income Continuous | -52,673 | -35,311 | -51,955 | -39,770 | -19,465 |
| Net Income | $-52,673 | $-35,311 | $-51,955 | $-39,770 | $-19,465 |
| EPS Basic Total Ops | -15.28 | -124.41 | -21.20 | -21.90 | -96.00 |
| EPS Basic Continuous Ops | -15.28 | -124.41 | -21.21 | -21.92 | -95.98 |
| EPS Diluted Total Ops | -15.28 | -124.41 | -21.20 | -21.90 | -96.00 |
| EPS Diluted Continuous Ops | -15.28 | -124.41 | -21.21 | -21.92 | -95.98 |
| EPS Diluted Before Non-Recurring Items | -15.28 | -25.20 | -21.20 | -21.90 | N/A |
| EBITDA(a) | $-53,582 | $-36,374 | $-54,560 | $-39,566 | $-19,532 |